Investing Ideas
/
Greek Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Greek Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

1 companies

Lavipharm

Market Cap: €123.3m

Engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, dermocosmetic, and healthcare products to physicians and pharmacists in Greece and internationally.

New

LAVI

€0.75

6.0%

-8.0%